New blood-clot drugs may add to gastrointestinal bleeding risk

07/22/2013 | PhysiciansBriefing.com

Gastrointestinal bleeding is more likely to occur with newer oral anticoagulants than with standard treatment, according to an analysis in the journal Gastroenterology. Researchers analyzed data on 151,578 patients who participated in 43 randomized, controlled studies and found that the risk was greatest for those undergoing therapy for venous thrombosis and acute coronary syndrome. "The current evidence, however, is based on a highly selected patient group with a low bleeding risk, disallowing a true reflection of future patients in daily clinical practice," researchers wrote.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Systems Test - V&V Engineer - 14000008LS
Abbott
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC